| 소아F-029 |
| 상사근마비 환자에서 술전에 하사근에 주사한 보툴리눔독소가 사시수술결과에 미치는 영향 |
| 경북대학교 의과대학 안과학교실(1), Federal University School of Medicine, Sergipe, BRAZIL(2), Neuro-ophthalmology Service, Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, USA(3) |
| 전보영(1,3), Marcelle V. Freire(2,3), Dean M. Cestari(3) |
|
목적 : To compare extraocular muscle (EOM) surgery with combined preoperative Onabotulinumtoxin A injection to the ipsilateral inferior oblique (IO) muscle for the treatment of superior oblique (SO) palsy
방법 : A retrospective review of medical records of patients with SO palsy who underwent surgical treatment between 2006 and 2015. Group 1 (n=12) underwent preoperative Onabotulinumtoxin A injection to the ipsilateral IO and then EOM surgery to correct hypertropia, while group 2 (n=12) underwent EOM surgery only. Comparisons were made of preoperative and postoperative vertical deviation angles in primary position and the amount of corrected hypertropia, postoperative drift and success rate (defined as less than 5 PD).
결과 : Preoperatively, there was no statistically meaningful difference in mean vertical deviation in primary position between the two groups (13.0 PD and 13.5 PD, respectively (p>0.05)). Mean vertical deviations in primary position at postoperative 1 week measurements were -0.2 PD and 1.8 PD in group 1 and 2 respectively, and -0.7 PD and 0.3 PD in group 1 and 2, respectively, in postoperative 3 months. Mean amount of postoperative drift toward hypertropia in primary position was 0.5 PD and 1.6 PD in group 1 and 2, respectively. Success rate of group 1 was 85% and that of group 2 was 77% (p>0.05).
결론 : Both EOM surgery and EOM surgery combined preoperative Onabotulinumtoxin A injection to the ipsilateral IO muscle were effective in the treatment of SO palsy. Our findings support the condition that there is no reason to avoid preoperative Onabotulinumtoxin A injection while waiting for the EOM surgery in patients with SO palsy.
|
| |